Evolving Role of Chemotherapy-Based Treatment of Metastatic Melanoma
SS Agarwala, MR Middleton, MB Atkins - Cutaneous Melanoma, 2020 - Springer
For many years the mainstay of treatment for metastatic melanoma, chemotherapy is much
less used today. Although a small minority of patients benefit from cytotoxic agents …
less used today. Although a small minority of patients benefit from cytotoxic agents …
Progress in the treatment of metastatic cutaneous melanoma.
JG Lenehan, DS Ernst - Oncology Exchange, 2015 - search.ebscohost.com
This review examines progress in the treatment of metastatic melanoma seen in the past 5
years. It focuses on the development of targeted therapies and immune checkpoint inhibitors …
years. It focuses on the development of targeted therapies and immune checkpoint inhibitors …
[PDF][PDF] Evolving Treatment Strategies in the Management of Metastatic Melanoma: Optimizing Immunotherapy Approaches for Improved Outcomes
RR Kudchadkar - Editorial Review Board - jmcmpub.org
Amazing progress in improving survival with metastatic melanoma has been made.
Checkpoint immunotherapy, especially in combinations, has changed the prognosis from …
Checkpoint immunotherapy, especially in combinations, has changed the prognosis from …
[HTML][HTML] Treatment of metastatic melanoma: an overview
The 10-year survival rate for patients with metastatic melanoma is less than 10%. Although
surgery and radiation therapy have a role in the treatment of metastatic disease, systemic …
surgery and radiation therapy have a role in the treatment of metastatic disease, systemic …
Chemotherapy for metastatic melanoma: time for a change?
HJ Gogas, JM Kirkwood… - … International Journal of …, 2007 - Wiley Online Library
Melanoma is a neoplasm with a rising incidence. Early‐stage melanoma is curable, but
advanced, metastatic melanoma almost uniformly is fatal, and patients with such advanced …
advanced, metastatic melanoma almost uniformly is fatal, and patients with such advanced …
Current systemic therapy for metastatic melanoma
SS Agarwala - Expert review of anticancer therapy, 2009 - Taylor & Francis
Metastatic melanoma remains a lethal disease with a long-term remission rate of less than
10%. Despite many years of research, there has not been a new drug approved in this …
10%. Despite many years of research, there has not been a new drug approved in this …
Metastatic melanoma: chemotherapy
E Bajetta, M Del Vecchio, C Bernard-Marty, M Vitali… - Seminars in …, 2002 - Elsevier
The incidence of cutaneous melanoma has been rapidly increasing, with an estimate of
47,700 new cases diagnosed in 2000 in the United States. In the early phase of its natural …
47,700 new cases diagnosed in 2000 in the United States. In the early phase of its natural …
[HTML][HTML] Treatment of advanced metastatic melanoma
P Quaglino, P Fava, L Tonella, M Rubatto… - Dermatology Practical …, 2021 - ncbi.nlm.nih.gov
The introduction in clinical practice of new drug compounds both targeted therapies anti-
BRAF and checkpoint inhibitors have largely improved our potential to manage advanced …
BRAF and checkpoint inhibitors have largely improved our potential to manage advanced …
[HTML][HTML] Chemotherapy in cutaneous melanoma: is there still a role?
Abstract Purpose of Review In the preceding decade, the management of metastatic
cutaneous melanoma has been revolutionised with the development of highly effective …
cutaneous melanoma has been revolutionised with the development of highly effective …
Metastatic melanoma treatment: Combining old and new therapies
RJ Davey, A van der Westhuizen… - Critical reviews in oncology …, 2016 - Elsevier
Metastatic melanoma is an aggressive form of cancer characterised by poor prognosis and a
complex etiology. Until 2010, the treatment options for metastatic melanoma were very …
complex etiology. Until 2010, the treatment options for metastatic melanoma were very …